EUVIMEDObjevte EUVIMED
Open access

Clinical Features and Surgical Outcomes in Patients With Central Skull Base Osteomyelitis

Jin Hyung Jung, So Hee Kang, Ji Heui Kim iD

Otolaryngology–Head and Neck Surgery · 2026-08 · 175 (2) · 316-325

DOI: 10.1002/ohn.70294 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, published online on 2026-05-22. Written by Jin Hyung Jung and 2 co-authors. Institution: Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Major MEDLINE topics: Osteomyelitis, Skull Base. 37 references. The full text is freely available in PubMed Central. Funded by: Asan Institute for Life Sciences.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objectives

Central skull base osteomyelitis (CSBO) is a rare but potentially life‐threatening condition primarily involving the sphenoid or occipital bones, with reported mortality rates of 30% to 50%. Owing to its low incidence, evidence‐based diagnostic and treatment guidelines remain limited. This study aimed to characterize the clinical features, microbiologic spectrum, and treatment outcomes of patients with CSBO. Study design Retrospective cohort study.

Setting

Single tertiary referral center.

Methods

This study included 22 patients diagnosed with CSBO between November 2013 and December 2022. Clinical data, including presenting symptoms, comorbidities, surgical interventions, microbiologic findings, antimicrobial regimens and duration, hospitalization length, and clinical outcomes, were analyzed.

Result

Diabetes mellitus was the most common underlying condition (n = 15, 68.2%). The predominant symptoms were headache (n = 14, 63.6%) and otologic complaints (n = 5, 22.7%). Surgical specimen cultures identified bacterial pathogens in 7 patients (32.0%), fungal pathogens in 9 (41.0%), and mixed bacterial‐fungal pathogens in 5 (23.0%). Nineteen patients (83.4%) underwent surgical debridement; earlier debridement was correlated with a shorter duration of antimicrobial therapy ( R = 0.545, P = .016). Complete remission was achieved in 19 patients (83.4%), and the overall mortality rate was 13.6%.

Conclusion

Pathogen identification through surgical sampling is crucial for the effective management of CSBO, enabling timely and targeted antimicrobial therapy. Surgical debridement appears to improve clinical outcomes and reduce treatment duration. Prompt diagnosis and early surgical intervention may therefore be essential for achieving a favorable prognosis in patients with CSBO.

Subjects

MeSH terms (MEDLINE)

OsteomyelitisSkull BaseHumansFemaleRetrospective StudiesMaleMiddle AgedTreatment OutcomeAdultAgedDebridement

Author keywords

antimicrobial agentsdebridementosteomyelitisskull base

Authors and institutions

  • Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID profiles: Ji Heui Kim

Funding

  • Asan Institute for Life Sciences

Cite

APA

Jung, J. H., Kang, S. H., & Kim, J. H. (2026). Clinical Features and Surgical Outcomes in Patients With Central Skull Base Osteomyelitis. Otolaryngology–Head and Neck Surgery, 175(2), 316-325. https://doi.org/10.1002/ohn.70294

Vancouver

Jung JH, Kang SH, Kim JH. Clinical Features and Surgical Outcomes in Patients With Central Skull Base Osteomyelitis. Otolaryngology–Head and Neck Surgery. 2026;175(2):316-325. doi:10.1002/ohn.70294

BibTeX
@article{Jung2026,
  author = {Jung, Jin Hyung and Kang, So Hee and Kim, Ji Heui},
  title = {Clinical Features and Surgical Outcomes in Patients With Central Skull Base Osteomyelitis},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2026},
  volume = {175},
  number = {2},
  pages = {316--325},
  doi = {10.1002/ohn.70294}
}
Start for free →